DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical

Abstract

A compound and method of making a compound for use as a diagnostic or therapeutic pharmaceutical comprises either a phosphorous or germanium core and at least two hydrazine groups forming a ligand for bonding to a metal extending from the phosphorous or germanium core.

Inventors:
 [1];  [1];  [1];  [1]
  1. Columbia, MO
Issue Date:
Research Org.:
Univ. of Missouri, Columbia, MO (United States)
OSTI Identifier:
870416
Patent Number(s):
5516940
Assignee:
Curators of University of Missouri (Columbia, MO)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
DOE Contract Number:  
FG02-89ER60875
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
multifunctional; ligand; diagnostic; therapeutic; pharmaceutical; compound; method; comprises; phosphorous; germanium; core; hydrazine; forming; bonding; metal; extending; therapeutic pharmaceutical; pharmaceutical comprises; multifunctional ligand; /999/252/

Citation Formats

Katti, Kattesh V, Volkert, Wynn A, Ketring, Alan R, and Singh, Prahlad R. Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical. United States: N. p., 1996. Web.
Katti, Kattesh V, Volkert, Wynn A, Ketring, Alan R, & Singh, Prahlad R. Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical. United States.
Katti, Kattesh V, Volkert, Wynn A, Ketring, Alan R, and Singh, Prahlad R. Mon . "Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical". United States. https://www.osti.gov/servlets/purl/870416.
@article{osti_870416,
title = {Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical},
author = {Katti, Kattesh V and Volkert, Wynn A and Ketring, Alan R and Singh, Prahlad R},
abstractNote = {A compound and method of making a compound for use as a diagnostic or therapeutic pharmaceutical comprises either a phosphorous or germanium core and at least two hydrazine groups forming a ligand for bonding to a metal extending from the phosphorous or germanium core.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Mon Jan 01 00:00:00 EST 1996},
month = {Mon Jan 01 00:00:00 EST 1996}
}

Works referenced in this record:

Differential cellular catabolism of 111In, 90Y and 125I radiolabeled T101 anti-CD5 monoclonal antibody
journal, January 1990

  • Naruki, Yukihiko; Carrasquillo, Jorge A.; Reynolds, James C.
  • International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, Vol. 17, Issue 2
  • https://doi.org/10.1016/0883-2897(90)90148-T

Synthesis and crystal and molecular structure of a technetium-hydralazino complex, [TcCl2(C8H5N4)(PPh3)2]·0.75C7H8
journal, July 1990


The chemistry of 99mTc-labeled radiopharmaceuticals
journal, January 1990


Heterocycles contenant du phosphore—XXIX
journal, January 1976


Current and future radiopharmaceuticals for brain imaging with single photon emission computed tomography
journal, October 1990


Production and Use of Prospective Radionuclides for Radioimmunotherapy
book, January 1988


Antibody radiolabeling, problems and promises
journal, January 1990


ESR spectra of seven-coordinated pentagonal bipyramidal copper(II) complexes
journal, January 1980


Darstellung von Thiophosphoryltrihydrazid und 1-Phenyl-2-difluorthiophosphoryl-hydrazin
journal, July 1967


Tumour targeting with radiolabelled macrocycle–antibody conjugates
journal, January 1990


Chelate radiochemistry: Cleavable linkers lead to altered levels of radioactivity in the liver
journal, January 1988


Radiotherapeutic agents: Properties, dosimetry, and radiobiologic considerations
journal, April 1979